Glaxosmithkline Share News (GSK)
GSK Share
GSK Share
GSK Share
GSK Share
GSK
GSK Share
GSK Level 2
GSK Live
GSK Broker
GSK Directors
GSK Financial
GSK
GSK Short
GSK
Last checked at -
Dec 2 (Reuters) - GlaxoSmithKline on Thursday said that a pre-clinical analysis of the antibody-based COVID-19 therapy it is developing with U.S. partner Vir has indicated that the drug also works against the new Omicron variant.Further tests wil...
Read moreBy Michael HoldenLONDON, Dec 1 (Reuters) - Britain said on Wednesday it had agreed deals to buy 114 million more Pfizer/BioNTech and Moderna COVID-19 vaccine shots, saying it had sped up signing the new contracts in light of the emergence of the n...
Read more
(Sharecast News) - GlaxoSmithKline said on Tuesday that it has appointed Phil Dormitzer as global head of vaccines R&D.
Read moreNov 30 (Reuters) - GSK has hired one of the scientists behind Pfizer's mRNA COVID-19 shot, Phil Dormitzer, as its global head of R&D for vaccines and he will join the British drugmaker from Dec. 3, GSK said on Tuesday.By poaching one of Pfizer's t...
Read more
LONDON BROKER RATINGS: Hochschild Mining hit with three downgrades
Read more* Review and advice to aid EU states with possible early use* Real-time rolling review of Pfizer pill, Paxlovid, anticipated* EU in talks with Pfizer and Merck over supply of their pills (Writes through with detail, advice on Merck pill)By Pushkal...
Read more* Review to aid EU states with early emergency use* Real-time rolling review of pill, Paxlovid, anticipated* EU in talks with Pfizer over supply, rival Merck more advanced (Adds background)By Pushkala AripakaNov 19 (Reuters) - The European Union's ...
Read moreLONDON MARKET CLOSE: Stocks mixed on Europe Covid resurgence fears
Read moreLONDON MARKET MIDDAY: FTSE left behind as CAC and DAX hit records
Read moreBy Ludwig BurgerNov 18 (Reuters) - Drugmakers have made some progress in restraining antibiotics overuse, which leads to drug-resistant infections, but have fallen short in making antibiotics more widely available in low-income countries, an influ...
Read more(Sharecast News) - The United States has signed about $1bn of contracts to buy the antibody-based Covid-19 treatment developed by GlaxoSmithKline and Vir Technology of the US, according to a report.
Read moreGSK gets USD1 billion US deals; Nucala is approved for three diseases
Read more(Sharecast News) - GlaxoSmithKline said the European Commission has approved its Nucala treatment for asthma and other nasal conditions.
Read more* Globally more than 750,000 doses of treatment secured* U.S. supply expected by mid-December* U.S. gave the drug emergency use approval in May (Writes through with detail)By Pushkala AripakaNov 17 (Reuters) - The United States has signed contracts ...
Read more* Globally more than 750,000 doses of treatment secured* U.S. supply expected by mid-December* U.S. gave the drug emergency use approval in May (Adds detail on drug, exec comment, background)By Pushkala AripakaNov 17 (Reuters) - The United States ha...
Read more
Last checked at